Cited by 5Substance Abuse Treatment and OutcomesMental Health Treatment and AccessAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Chronic Physical Health Problems Moderate Changes in Depression and Substance Use Among Dual Diagnosed Individuals During and After Treatment

Open access
Cui, Ruifeng, Tate, Susan R., Cummins, Kevin, Skidmore, Jessica R., Brown, Sandra A.·2015·Substance Use & Misuse

Abstract

BACKGROUND: Physical illnesses frequently co-occur with depression and substance use disorders and may impact their improvement. Physical illness symptoms may overlap with or exacerbate somatic symptoms of depression. Individuals may use substances to cope with symptoms of physical illness. OBJECTIVES: We examined whether chronic physical health problems moderated changes in depression and substance use among dual diagnosed individuals during and in the year following treatment. METHODS: Participants were recruited from a Veterans Affairs dual diagnosis outpatient program between March 2000 and November 2007 and were randomized to either Integrated Cognitive-Behavioral Therapy or Twelve-Step Facilitation Therapy. A total of 214 veterans with assessment data for the variables of interest were included in analyses. Participants completed quarterly depression, substance use, and health assessments over an 18 month period. We used linear-mixed effects models to analyze patterns of change for depression and substance use. RESULTS: Individuals with severe chronic health problems and higher intake depression showed slower improvements in both nonsomatic and somatic depression symptoms. Individuals with severe chronic health problems and higher midtreatment substance use showed less improvement in substance use. CONCLUSIONS: Assessing and addressing physical health issues during depression and substance use disorder treatment may improve outcomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/10826084.2014.962052

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Pharmacological treatment of ADHD in adolescents, including with psychostimulant medications, reduces the risk for development of SUD.

    “research has shown that pharmacological treatment of ADHD in this population, including with psychostimulant medications, reduces the risk for development of SUD.168”

    From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [168]

    The Methods > Participants section describes a VA clinic sample with substance dependence and major depressive disorder (page not available). The Methods > Procedure section mentions psychotropic medications but does not identify ADHD treatment or report whether it reduces later SUD risk. Searches for adolescent ADHD treatment, psychostimulants, and prevention of substance dependence found no passage addressing the claim. (LLM, conf=0.77)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 56 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Cui, R., Tate, S. R., Cummins, K., Skidmore, J. R., & Brown, S. A.
Affiliations
  • VA San Diego Healthcare System (US)
  • University of California San Diego (US)
Corresponding author
Tate, Susan R.
Venue
Substance Use & Misuse
Published
2014-10-07
Volume
50
Issue
2
Pages
174-183
ISSN
  • 1082-6084 (ISSN-L)
  • 1532-2491
OpenAlex
W2120071139
Cited by
5
References
56
Citations by year
2025: 1 · 2024: 1 · 2020: 1 · 2017: 1 · 2016: 1
FWCI
0.51
Type
journal article
Language
en
Open access
Locations
  • Substance Use & Misuse (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute on Alcohol Abuse and Alcoholism (T32AA013525)
  • National Institute of Mental Health
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
dual diagnosis, depression, substance use disorders, somatic symptoms of depression, veterans, cognitive behavioral therapy, twelve-step facilitation, treatment outcomes, comorbidities
MeSH terms
Adult, Depressive Disorder, Female, Health Status, Humans, Male, Middle Aged, Psychotherapy, Cognitive Behavioral Therapy, Treatment Outcome, Diagnosis, Dual (Psychiatry), Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review